17th Annual Bioprocessing Summit 2025
ÀÏÁ¤ : 2025³â 8¿ù 18-21ÀÏ
°³ÃÖ: Omni Boston Hotel at the Seaport, Boston, USA

Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

Catalog Download
Catalog

¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ¾÷°èÀÇ ÀÇ»ç°áÁ¤ÀÚ¿ë Ç÷¡±×½Ê À̺¥Æ®

2025³â ÇÁ·Î±×·¥

Stream IconUPSTREAM PROCESSING
¾÷½ºÆ®¸² ÇÁ·Î¼¼½Ì
Stream IconDOWNSTREAM PROCESSING
´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì
Stream IconAI AND DIGITALIZATION
AI¡¤µðÁöÅÐÈ­
Stream IconANALYTICAL & QUALITY
ºÐ¼®¹ý¡¤Ç°Áú
Stream IconGENE THERAPY
À¯ÀüÀÚ Ä¡·á
Stream IconCELL THERAPY
¼¼Æ÷Ä¡·á
Stream IconRNA AND GENETIC MEDICINES
RNA¡¤À¯Àü ÀÇ·á
Stream IconFORMULATION & STABILITY
Á¦Á¦¡¤¾ÈÁ¤¼º
Cell Line Engineering & Development
¼¼Æ÷ÁÖ ¿£Áö´Ï¾î¸µ¡¤¼¼Æ÷ÁÖ °³¹ß
Intensified & Continuous Bioprocessing
°­È­ 󸮡¤¿¬¼Ó ó¸®
Training Seminar
ML/AI for Biomanufacturing
Æ®·¹ÀÌ´× ¼¼¹Ì³ª(¹ÙÀÌ¿ÀÁ¦Á¶¿ë ML/AI)
Accelerating Analytical Development
ºÐ¼®¹ý °³¹ßÀÇ °¡¼Ó
Gene Therapy CMC & Analytics
À¯ÀüÀÚ Ä¡·á CMC¿Í ºÐ¼®
Cell Therapy CMC & Analytics
¼¼Æ÷Ä¡·á CMC¿Í ºÐ¼®
RNA Development, CMC & Manufacturing
RNA °³¹ß¡¤CMC¡¤Á¦Á¶
Formulation, Stability & Delivery
Á¦Á¦¡¤¾ÈÁ¤¼º¡¤Àü´Þ
Cell Culture Optimization & Scale-Up
¼¼Æ÷¹è¾ç ÃÖÀûÈ­¿Í ½ºÄÉÀÏ ¾÷
Advances in Purification & Recovery
Á¤Á¦¡¤È¸¼öÀÇ Áøº¸
Digital Transformation & AI in Bioprocess
¹ÙÀÌ¿ÀÇÁ·Î¼¼½º¿ë µðÁöÅÐ Æ®·£½ºÆ÷¸ÞÀ̼ǰú AI
Next-Generation Analytical Methods
Â÷¼¼´ë ºÐ¼®¹ý
Gene Therapy Manufacturing
À¯ÀüÀÚ Ä¡·á Á¦Á¶
Cell Therapy Manufacturing
¼¼Æ÷Ä¡·á Á¦Á¶
Gene Therapy Manufacturing
À¯ÀüÀÚ Ä¡·á Á¦Á¶
Training Seminar
Formulation of Biopharmaceuticals
Æ®·¹ÀÌ´× ¼¼¹Ì³ª(¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¦)
Testimonials

Bioprocessing Summit 2025

¹ÙÀÌ¿ÀÇÁ·Î¼¼½ÌÀÇ ¹Ì·¡¸¦ Çü¼ºÇÏ´Â »ç°í ¸®´õ ¹× À̳뺣ÀÌÅÍ·Î ±¸¼ºµÈ ±Û·Î¹ú Ä¿¹Â´ÏƼ¿¡ Âü¿©Çϼ¼¿ä. ÃÖ÷´Ü ¿¬±¸¸¦ »ìÆìº¸°í, ¾÷°è Àü¹®°¡¿Í ÀλçÀÌÆ®¸¦ °øÀ¯Çϸç, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º R&D, È®Àå, ǰÁú ¹× ºÐ¼®ÀÇ °úÁ¦¸¦ ÇØ°áÇϼ¼¿ä.

¼­¹Ô ³»¿ë :

  • ÁÖ¿ä ÄÁÆÛ·±½º ¼¼¼Ç¿¡¼­´Â ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°ø
  • ¾÷°è ÆÄÀÌ¿À´Ï¾î°¡ ÁÖµµÇÏ´Â »ó¼¼ Æ®·¹ÀÌ´× ¼¼¹Ì³ª
  • Ãֽбâ¼úÀ» ¼Ò°³ÇÏ´Â ¸Å·ÂÀûÀÎ Àü½ÃȦ
  • µ¿·á ¹× Àü¹®°¡¿Í Á¦ÈÞÇÏ´Â ³×Æ®¿öÅ· ±âȸ
  • ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì, ¼¼Æ÷¹è¾ç, Á¤Á¦, ¼¼Æ÷Ä¡·á¡¤À¯ÀüÀÚ Ä¡·á µîÀÇ AI¡¤±â°èÇнÀ¿¡ °üÇÑ Àü¿ë ÇÁ·Î±×·¡¹Ö

Àü¹®¼ºÀ» ³ôÀÌ°í ³×Æ®¿öÅ©¸¦ È®´ëÇϰí, Çõ½ÅÀ» ÃßÁøÇϼ¼¿ä. ¹Ì·¡ÀÇ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ¼Ö·ç¼ÇÀ» Çü¼ºÇÏ´Â ´ëÈ­¿¡ Âü¿©Çϼ¼¿ä.

1,500

Attendees

300

Presentations

100

Research Posters

13

Conference Tracks

90

Exhibitors

2025 Premier Sponsors

Cygnus_New  

Àüü ½ºÆù¼­ º¸±â

2025³â Ç÷¹³Ê¸® ±âÁ¶ °­¿¬

Increasing mAb Output Ten-Fold while Reducing Natural Resources Through Digitalization and New Technologies

Raghavan V. Venkat, PhD

CHAIRPERSON:
Raghavan V. Venkat, PhD
Senior Vice President, Bioprocess Development, AstraZeneca

Lisbet Jensen Young

Lisbet Jensen Young
Vice President & General Manager, AstraZeneca


Plenary Fireside Chat:

Innovation and Investment for Biomanufacturing Future Medicines

Ran Zheng

MODERATOR:
Ran Zheng
CEO, Landmark Bio

Daniella Kranjac

PANELIST:
Daniella Kranjac
Founding General Partner, Dynamk Capital LLC

David Y H Chang, CEO

PANELIST:
David Y. H. Chang, CEO
Taiwan Bio-Manufacturing Company (TBMC)

Bo Wiinberg, PhD

PANELIST:
Bo Wiinberg, PhD
Chief Business Development Officer, Novo Nordisk Foundation Cellerator

Paul Lewus, PhD

PANELIST:
Paul Lewus, PhD
Vice President, Site Operations, Amgen Inc.